𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Association of two mutations in the CHEK2 gene with breast cancer

✍ Scribed by Natalia Bogdanova; Natalia Enβen-Dubrowinskaja; Sergei Feshchenko; Gennady I. Lazjuk; Yuri I. Rogov; Olaf Dammann; Michael Bremer; Johann H. Karstens; Christof Sohn; Thilo Dörk

Publisher
John Wiley and Sons
Year
2005
Tongue
French
Weight
148 KB
Volume
116
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The 1100delC mutation of the cell cycle checkpoint kinase 2 (CHEK2) gene confers an increased risk for breast cancer, but the clinical impact of other CHEK2 gene variants remains unclear. We determined the frequency of two functionally relevant CHEK2 gene mutations, I157T and IVS2+1G > A, in two large series of breast cancer cases and controls from two independent populations. Our first series consisted of a hospital‐based cohort of 996 German breast cancer cases and 486 population controls, and the second series consisted of 424 breast cancer patients and 307 population controls from the Republic of Belarus. The missense substitution I157T was identified in 22/996 cases (2.2%) vs. 3/486 controls (0.6%; OR = 3.6, 95% CI 1.1–12.2, p = 0.044) in the German population and in 24/424 cases (5.7%) vs. 4/307 controls (1.3%; OR = 4.5, 95% CI 1.6–13.2, p = 0.005) in the Byelorussian cohorts. The splicing mutation IVS2+1G > A was infrequent in both populations, being observed in 3/996 German and 4/424 Byelorussian patients (0.3% and 0.9%, respectively) and in 1/486 German controls (0.2%; adjusted OR = 4.0, 95% CI 0.5–30.8, p = 0.273). Heterozygous CHEK2 mutation carriers tended to be diagnosed at an earlier age in both populations, but these differences did not reach statistical significance. Family history of breast cancer did not differ between carriers and noncarriers. Our data indicate that the I157T allele, and possibly the IVS2+1G > A allele, of the CHEK2 gene contribute to inherited breast cancer susceptibility. © 2005 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Limited relevance of the CHEK2 gene in h
Limited relevance of the CHEK2 gene in hereditary breast cancer
✍ Michael R. Dufault; Beate Betz; Barbara Wappenschmidt; Wera Hofmann; Katrin Band 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 215 KB 👁 1 views

## Abstract To establish the importance of __CHEK2__ mutations for familial breast cancer incidence in the German population, we have screened all 14 of the coding exons in 516 families negative for mutations in both the __BRCA1__ and __BRCA2__ genes. We found 12 distinct variants in 30 unrelated p

Germline mutations in the CHEK2 kinase g
Germline mutations in the CHEK2 kinase gene are associated with an increased risk of bladder cancer
✍ Elżbieta Złowocka; Cezary Cybulski; Bohdan Górski; Tadeusz Dębniak; Marcin Słoje 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 76 KB 👁 2 views

## Abstract Germline mutations in __CHEK2__ have been associated with a range of cancer types but little is known about disease risks conveyed by __CHEK2__ mutations outside of the context of breast and prostate cancer. To investigate whether __CHEK2__ mutations confer an increased risk of bladder

A recurrent CHEK2 p.H371Y mutation is as
A recurrent CHEK2 p.H371Y mutation is associated with breast cancer risk in Chinese women
✍ Yin Liu; Ji Liao; Ye Xu; Weiqiu Chen; Dongyun Liu; Tao Ouyang; Jinfeng Li; Tianf 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

The association between the CHEK2 and breast cancer risk in Chinese women is unknown. Here, we screened the full CHEK2 coding sequence in 118 Chinese familial breast cancer cases who are negative for mutations in BRCA1 and BRCA2, one recurrent mutation, CHEK2 c.1111C4T (p.H371Y), was identified in f

BRCA2 gene mutations in Greek patients w
BRCA2 gene mutations in Greek patients with familial breast cancer
✍ Athanasios Armakolas; Angela Ladopoulou; Irene Konstantopoulou; B. Pararas; Ilia 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB 👁 1 views

Family history is a well-recognized risk factor for the development of breast cancer. The isolation of BRCA1 and BRCA2 genes, the two major predisposing genes in familial and to early onset breast and ovarian cancer, has resulted to the identification of a large number of families with mutations in

The breast cancer low-penetrance allele
The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population
✍ Ana Osorio; Raquel Rodríguez-López; Orland Díez; Miguel de la Hoya; José Ignacio 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 127 KB 👁 1 views

## Abstract Searching for low‐penetrance genes involved in breast cancer susceptibility has been a field of interest in the last few years. Recently, the CHEK 2 gene, involved in DNA damage and replication checkpoints, has been pointed out as a good candidate; moreover, a specific variant in this g